You are here

  • Home
  • Archive
  • Volume 67, Issue 9
  • The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data

Article info

Article menu
Download PDFPDF
Extended report
The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data

Authors

  1. W Kievit, Department of Rheumatology (470), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands; w.kievit{at}reuma.umcn.nl
View Full Text

Citation

Kievit W, Adang EM, Fransen J, et al
The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data
Annals of the Rheumatic Diseases 2008;67:1229-1234.

Publication history

  • Accepted December 20, 2007
  • First published January 3, 2008.
Online issue publication 
August 12, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism